Brickell Biotech Stock Gross Profit
BBIDelisted Stock | USD 1.79 0.34 23.45% |
Brickell Biotech fundamentals help investors to digest information that contributes to Brickell Biotech's financial success or failures. It also enables traders to predict the movement of Brickell Stock. The fundamental analysis module provides a way to measure Brickell Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Brickell Biotech stock.
Brickell |
Brickell Biotech Company Gross Profit Analysis
Brickell Biotech's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Brickell Biotech Gross Profit | (27.83 M) |
Most of Brickell Biotech's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Brickell Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Brickell Biotech reported (27.83 Million) of gross profit. This is 101.24% lower than that of the Biotechnology sector and 102.93% lower than that of the Health Care industry. The gross profit for all United States stocks is 100.1% higher than that of the company.
Brickell Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Brickell Biotech's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Brickell Biotech could also be used in its relative valuation, which is a method of valuing Brickell Biotech by comparing valuation metrics of similar companies.Brickell Biotech is currently under evaluation in gross profit category among its peers.
Brickell Fundamentals
Return On Equity | -1.57 | |||
Return On Asset | -0.8 | |||
Operating Margin | (6.58) % | |||
Current Valuation | (8.35 M) | |||
Shares Outstanding | 2.87 M | |||
Shares Owned By Insiders | 1.20 % | |||
Shares Owned By Institutions | 13.07 % | |||
Number Of Shares Shorted | 189.59 K | |||
Price To Earning | (35.16) X | |||
Price To Book | 0.41 X | |||
Price To Sales | 1.45 X | |||
Revenue | 404 K | |||
Gross Profit | (27.83 M) | |||
EBITDA | (39.38 M) | |||
Net Income | (39.47 M) | |||
Cash And Equivalents | 17.29 M | |||
Cash Per Share | 6.52 X | |||
Total Debt | 69 K | |||
Debt To Equity | 0 % | |||
Current Ratio | 4.36 X | |||
Book Value Per Share | 5.81 X | |||
Cash Flow From Operations | (36.15 M) | |||
Short Ratio | 0.62 X | |||
Earnings Per Share | (0.42) X | |||
Target Price | 17.83 | |||
Number Of Employees | 16 | |||
Beta | 0.0796 | |||
Market Capitalization | 6.75 M | |||
Total Asset | 29.72 M | |||
Retained Earnings | (145.37 M) | |||
Working Capital | 24.79 M | |||
Current Asset | 52.66 M | |||
Current Liabilities | 5.61 M | |||
Net Asset | 29.72 M |
About Brickell Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Brickell Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brickell Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brickell Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Brickell Stock
If you are still planning to invest in Brickell Biotech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Brickell Biotech's history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |